- Home
- OPTT vs IGMS Comparison
OPTT vs IGMS Comparison
Compare OPTT & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- IGMS
- Stock Information
- Founded
- OPTT 1984
- IGMS 1993
- Country
- OPTT United States
- IGMS United States
- Employees
- OPTT N/A
- IGMS N/A
- Industry
- OPTT Electric Utilities: Central
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- OPTT Utilities
- IGMS Health Care
- Exchange
- OPTT Nasdaq
- IGMS Nasdaq
- Market Cap
- OPTT 89.7M
- IGMS 81.9M
- IPO Year
- OPTT 2007
- IGMS 2019
- Fundamental
- Price
- OPTT $0.52
- IGMS $1.28
- Analyst Decision
- OPTT
- IGMS Hold
- Analyst Count
- OPTT 0
- IGMS 8
- Target Price
- OPTT N/A
- IGMS $6.00
- AVG Volume (30 Days)
- OPTT 8.9M
- IGMS 542.3K
- Earning Date
- OPTT 07-24-2025
- IGMS 08-13-2025
- Dividend Yield
- OPTT N/A
- IGMS N/A
- EPS Growth
- OPTT N/A
- IGMS N/A
- EPS
- OPTT N/A
- IGMS N/A
- Revenue
- OPTT $5,861,000.00
- IGMS $145,050,000.00
- Revenue This Year
- OPTT N/A
- IGMS $252.44
- Revenue Next Year
- OPTT N/A
- IGMS $46.48
- P/E Ratio
- OPTT N/A
- IGMS N/A
- Revenue Growth
- OPTT 6.08
- IGMS 4882.82
- 52 Week Low
- OPTT $0.14
- IGMS $0.92
- 52 Week High
- OPTT $1.75
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- OPTT 42.45
- IGMS 50.36
- Support Level
- OPTT $0.50
- IGMS $1.25
- Resistance Level
- OPTT $0.90
- IGMS $1.33
- Average True Range (ATR)
- OPTT 0.07
- IGMS 0.02
- MACD
- OPTT -0.02
- IGMS -0.00
- Stochastic Oscillator
- OPTT 6.05
- IGMS 37.50
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.